Pharmacy Times

NOVEMBER 11, 2024

The regulatory approval corresponds with positive safety and efficacy data from the FELIX trial.

FDA 145

FDA 145

Drug Topics

NOVEMBER 11, 2024

Lauren Angelo, PharmD, MBA, discusses effective ways pharmacists can educate and encourage their communities on the importance of flu vaccination.

Vaccines 142

Vaccines 142

Pharmacy Times

NOVEMBER 11, 2024

Glucagon-like peptide-1 agonists have increasingly showed potential for treating liver fibrosis in patients, which disproportionately affects those who are overweight or have obesity.

145

145

pharmaphorum

NOVEMBER 11, 2024

Discover an expert perspective on how artificial intelligence is transforming the drug submission and approval process in the pharmaceutical industry. Explore the evolving role of AI in drug development.

127

127

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

NOVEMBER 11, 2024

In the trial, lumateperone had a significantly longer time to relapse in patients treated compared to placebo.

132

132

Fierce Healthcare

NOVEMBER 11, 2024

The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds. | The third quarter of 2023 was another mixed bag for major insurers as they continue to grapple with significant headwinds.

Insurance 127

Insurance 127

pharmaphorum

NOVEMBER 11, 2024

Mass General Brigham researchers have developed an AI that can spot hidden cases of long COVID from electronic health records

126

126

Pharmacy Times

NOVEMBER 11, 2024

Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.

123

123

Drug Topics

NOVEMBER 11, 2024

Research has found that children and young adults with overweight or obesity may be at a significantly increased risk of developing long COVID.

112

112

Fierce Pharma

NOVEMBER 11, 2024

Watch out, Gilead and Novartis: there's a new CAR-T in town. | Autolus' Aucatzyl has become the first CAR-T approved by the FDA without a REMS mandate. And the company is ready to hit the ground running, facing Gilead and Novartis as its competitors.

FDA 112

FDA 112

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

NOVEMBER 11, 2024

Accountable care organizations in the ACO Reach program can claim credit for saving the Centers for Medicare & Medicaid Services (CMS) hundreds of millions of dollars | CMS released favorable savings results for ACO REACH Model participants, as industry group NAACOS begins to push for the program's extension through 2030.

109

109

Pharmacy Times

NOVEMBER 11, 2024

If accepted, daratumumab would be the first approved treatment for smoldering multiple myeloma.

FDA 107

FDA 107

Pharmaceutical Technology

NOVEMBER 11, 2024

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy (REMS) programme.

FDA 105

FDA 105

pharmaphorum

NOVEMBER 11, 2024

Autolus gets its first product approval, an FDA green light for anti-CD19 CAR-T Aucatzyl for B-cell acute lymphoblastic leukaemia

FDA 103

FDA 103

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

NOVEMBER 11, 2024

BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology Excellence Awards.

105

105

Pharmacy Times

NOVEMBER 11, 2024

Participants who completed the curriculum had answered 82% of the post-test correctly.

101

101

pharmaphorum

NOVEMBER 11, 2024

AbbVie's $8.7bn play for Cerevel looks like a poor bet as its lead schizophrenia drug flunks two phase 2 trials, but which rival stands to benefit?

101

101

Compounding Pharmacy of America

NOVEMBER 11, 2024

New supplements and nutraceuticals seem to appear on the market every day, and some of these substances gain popularity very quickly due to their benefits. It’s important to have a balanced diet that’s dense in nutrients and minerals, and many people take supplements to provide the nutrients their everyday diets lack. The post Anti-Aging Benefits of High Potency Resveratrol appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 98

Compounding Pharmacies Compounding 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

NOVEMBER 11, 2024

Kaiser Permanente posted a $608 million operating loss in the third quarter as it faces high medical expenses due to higher-than-expected utilization of services, patient acuity and pharm | The company said the loss was influenced by higher-than-anticipated patient volumes and cost, borne by the whole industry, and system-specific hardships like a late Medicaid true-up and facility costs.

96

96

pharmaphorum

NOVEMBER 11, 2024

FDA starts review of Unicycive's drug for hyperphosphataemia in patients with chronic kidney disease on dialysis, aiming to improve on onerous phosphate binder therapy

FDA 96

FDA 96

Pharmacy Times

NOVEMBER 11, 2024

If approved, zongertinib may be a new first-line oral tyrosine kinase inhibitor (TKI) for patients with HER2-mutated non-small cell lung cancer (NSCLC), a transformative step in TKI drug development.

94

94

The Checkup by Singlecare

NOVEMBER 11, 2024

Though often referred to as cashew nuts, this crunchy treat is actually the kidney-shaped seed of a cashew apple, a tropical fruit cultivated in Brazil and India. Rich in nutrients, healthy fats, protein, vitamins, and minerals, cashews are linked to health benefits such as reduced inflammation , increased energy, and more. Read on to learn all of the ways eating cashews can improve your overall wellness, plus some tasty and creative ways to add them to your daily diet.

Immunization 89

Immunization Compounding Communication 89

Fierce Healthcare

NOVEMBER 11, 2024

Healthcare company Astrana Health plans to acquire certain businesses and assets of Prospect Health System in a $745 million deal that will expand its provider care network. | Healthcare company Astrana Health plans to acquire certain businesses and assets of Prospect Health System in a $745 million deal to expand its provider care network.

76

76

The Guardian - Pharmaceutical Industry

NOVEMBER 11, 2024

Experts say once-a-day varenicline tablet reduces nicotine cravings and side-effects from cutting out tobacco Hundreds of thousands of smokers will be given a pill that increases people’s chances of quitting, in a move that NHS bosses believe will save thousands of lives. About 85,000 people a year in England will be offered the chance to use varenicline, a once-a-day tablet that experts say is as effective as vapes at helping people to kick the habit.

67

67

Fierce Healthcare

NOVEMBER 11, 2024

Meharry Medical College in Nashville, Tennessee, is collaborating with Oracle on a new project to advance healthcare access, innovation and education in Middle Tennessee and beyond. | The organizations plan to establish a joint research collaborative focused on precision medicine and health informatics, a health innovation hub and a community care and wellness center in Nashville.

120

120

Pharmaceutical Technology

NOVEMBER 11, 2024

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine mRESVIA, designed to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals aged 60 and over.

Vaccines 64

Vaccines 64

The Checkup by Singlecare

NOVEMBER 11, 2024

Finding the right medication to manage a mental health condition is difficult, and it can take some trial and error to settle on an effective treatment plan. Two commonly prescribed medications for various mental health conditions are trazodone and Lexapro. As a brand-name prescription drug, Lexapro is FDA -approved to treat major depressive disorder and anxiety disorders.

FDA 52

FDA Labelling 52

Pharmaceutical Commerce

NOVEMBER 11, 2024

The conference returns to Lyon, France and promises a timely and relevant agenda that attendees will resonate with.

59

59

Pharmacy Times

NOVEMBER 11, 2024

CagriSema is a subcutaneous injectable combination of cagrilintide and semaglutide that is currently in phase 3 trials.

56

56

Pharmaceutical Commerce

NOVEMBER 11, 2024

The latest news for pharma industry insiders.

59

59

Fierce Healthcare

NOVEMBER 11, 2024

Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a statement on Monday. | Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a statement on Monday.

56

56

The Checkup by Singlecare

NOVEMBER 11, 2024

If you’re using Wegovy (semaglutide) for weight loss, there’s a small chance you may unexpectedly experience sulfur-tasting burps. This discomfort can catch you off guard and leave you wondering why it’s happening. While uncommon, this side effect can disrupt your daily life, making you hesitant to socialize or enjoy meals with others. Fortunately, there are ways to manage these bothersome sulfur burps.

Dosage 52

Dosage Compounding 52

Fierce Healthcare

NOVEMBER 11, 2024

| LexisNexis® Risk Solutions Launches Healthcare DataWake Podcast to Address Equity, Data, Diversity and More

52

52